Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers and Outcomes in patients with COVID-19: A Systematic Review and Meta-Analysis.

Kevin Bryan Lo,Ruchika Bhargav,Grace Salacup,Jerald Pelayo,Jeri Albano,Peter A. McCullough,Janani Rangaswami

Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers and Outcomes in patients with COVID-19: A Systematic Review and Meta-Analysis.

2020

Kevin Bryan Lo
Ruchika Bhargav
Grace Salacup
Jerald Pelayo
Jeri Albano
Peter A. McCullough
Janani Rangaswami

There remains controversy over the usage of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in patients with coronavirus disease 2019 (COVID-19) given the...

Keywords:

severe disease
Angiotensin II Receptor Blockers
Coronavirus disease 2019
in patient
Pharmacology
2019 20 coronavirus outbreak
Angiotensin-converting enzyme
Enzyme
Meta-analysis
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations